Literature DB >> 20491653

In vivo uptake of a haem analogue Zn protoporphyrin IX by the human malaria parasite P. falciparum-infected red blood cells.

Robson Sartorello1, Alexandre Budu, Piero Bagnaresi, Carlos A H Fernandes, Paloma M Sato, Vânia B Bueno, Marcos R M Fontes, Pedro L Oliveira, Gabriela O Paiva-Silva, Simone V Alves, Luis E S Netto, Luiz H Catalani, Celia R S Garcia.   

Abstract

The cellular traffic of haem during the development of the human malaria parasite Plasmodium falciparum, through the stages R (ring), T (trophozoite) and S (schizonts), was investigated within RBC (red blood cells). When Plasmodium cultures were incubated with a fluorescent haem analogue, ZnPPIX (Zn protoporphyrin IX) the probe was seen at the cytoplasm (R stage), and the vesicle-like structure distribution pattern was more evident at T and S stages. The temporal sequence of ZnPPIX uptake by P. falciparum-infected erythrocytes shows that at R and S stages, a time-increase acquisition of the porphyrin reaches the maximum fluorescence distribution after 60 min; in contrast, at the T stage, the maximum occurs after 120 min of ZnPPIX uptake. The difference in time-increase acquisition of the porphyrin is in agreement with a maximum activity of haem uptake at the T stage. To gain insights into haem metabolism, recombinant PfHO (P. falciparum haem oxygenase) was expressed, and the conversion of haem into BV (biliverdin) was detected. These findings point out that, in addition to haemozoin formation, the malaria parasite P. falciparum has evolved two distinct mechanisms for dealing with haem toxicity, namely, the uptake of haem into a cellular compartment where haemozoin is formed and HO activity. However, the low Plasmodium HO activity detected reveals that the enzyme appears to be a very inefficient way to scavenge the haem compared with the Plasmodium ability to uptake the haem analogue ZnPPIX and delivering it to the food vacuole.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20491653     DOI: 10.1042/CBI20090427

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  6 in total

1.  Direct tests of enzymatic heme degradation by the malaria parasite Plasmodium falciparum.

Authors:  Paul A Sigala; Jan R Crowley; Samantha Hsieh; Jeffrey P Henderson; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

2.  Biliverdin targets enolase and eukaryotic initiation factor 2 (eIF2α) to reduce the growth of intraerythrocytic development of the malaria parasite Plasmodium falciparum.

Authors:  Eduardo Alves; Fernando V Maluf; Vânia B Bueno; Rafael V C Guido; Glaucius Oliva; Maneesh Singh; Pedro Scarpelli; Fahyme Costa; Robson Sartorello; Luiz H Catalani; Declan Brady; Rita Tewari; Celia R S Garcia
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

Review 3.  Iron deficiency or anemia of inflammation? : Differential diagnosis and mechanisms of anemia of inflammation.

Authors:  Manfred Nairz; Igor Theurl; Dominik Wolf; Günter Weiss
Journal:  Wien Med Wochenschr       Date:  2016-08-24

4.  TSPO ligands stimulate ZnPPIX transport and ROS accumulation leading to the inhibition of P. falciparum growth in human blood.

Authors:  I Marginedas-Freixa; C Hattab; G Bouyer; F Halle; A Chene; S D Lefevre; M Cambot; A Cueff; M Schmitt; B Gamain; J J Lacapere; S Egee; F Bihel; C Le Van Kim; M A Ostuni
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

Review 5.  Porphyrin Derivative Nanoformulations for Therapy and Antiparasitic Agents.

Authors:  Daiana K Deda; Bernardo A Iglesias; Eduardo Alves; Koiti Araki; Celia R S Garcia
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411

6.  Evidence for Regulation of Hemoglobin Metabolism and Intracellular Ionic Flux by the Plasmodium falciparum Chloroquine Resistance Transporter.

Authors:  Andrew H Lee; Satish K Dhingra; Ian A Lewis; Maneesh K Singh; Amila Siriwardana; Seema Dalal; Kelly Rubiano; Matthias S Klein; Katelynn S Baska; Sanjeev Krishna; Michael Klemba; Paul D Roepe; Manuel Llinás; Celia R S Garcia; David A Fidock
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.